Speaker illustration

Mrs Sofia Bomholtz

Copenhagen N (Denmark)

Mechanisms of action of the small conductance Ca2+-activated K+-channel modulator AP30663, a novel compound being developed for treatment of atrial fibrillation in man

Event: ESC CONGRESS 2019

Topic: Antiarrhythmic Pharmacotherapy

Session: Preclinical pharmacotherapy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk